Ncardia

Ncardia is a biotech company in Leiden, Netherlands, founded in 2011. It has raised $60.0M across 2 rounds, most recently a $60.0M Growth Equity in November 2021.

Employees
51–200
Founded
2011
Total Funding
$60.0M
Last Round
$60.0M Growth EquityNov 2021
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 2 funding rounds and 6 investors for this company. The full record is or through the API.

About

It lists 51–200 employees. It has raised $60.0M in total across 2 rounds, most recently a $60.0M Growth Equity round in Nov 2021. Investors include Welsh, Carson, Anderson & Stowe, InnovationQuarter and SRIW.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Growth EquityGrowth EquityNov 2021
$60.0M

Sign up to see all 2 events

Funding: Growth Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

AsymchemIPO

Asymchem is a pharmaceutical CDMO providing R&D, chemistry, manufacturing, and control services t...

Tianjin, China5001–10000Biotech, Drug Discovery
Private EquityTotal funding$2.3BFeb 2020
Abogen Biosciences

Abogen Biosciences develops RNA therapeutics using integrated mRNA design, lipid nanoparticle del...

Suzhou, China201–500Biotech, Drug Discovery
Extension RoundTotal funding$1.2BNov 2021
Eikon TherapeuticsIPO

Late-stage biopharma using single-molecule tracking, AI, and engineering to discover and develop ...

Hayward, United States201–500Artificial Intelligence, Biotech
Series DTotal funding$1.1BFeb 2025
Xaira Therapeutics

Xaira Therapeutics is an integrated biotechnology company driving advances in artificial intellig...

South San Francisco, United States51–200Artificial Intelligence, Biotech
Series ATotal funding$1.0BApr 2024
OricIPO

San Diego-based clinical stage biopharmaceutical company focused on the development of small mole...

South San Francisco, United States51–200Biotech, Healthcare
Private EquityTotal funding$647.0MFeb 2026
Neumora TherapeuticsIPO

Clinical-stage biopharmaceutical developing precision medicines targeting novel mechanisms to tre...

Watertown, United States51–200Biotech, Drug Discovery
Series BTotal funding$612.0MOct 2022

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Ncardia on Indexed.vc
<a href="https://indexed.vc/companies/ncardia"><img src="https://indexed.vc/api/badge/company/ncardia" alt="Ncardia on Indexed.vc" width="260" height="76" /></a>